Lesson 1 of 0
In Progress

CME Info

Title: “Normal” Spirometry

Release date: January 18, 2019

Expiration date: January 18, 2021

Estimated time to complete activity: 1.0 hours

Hardware and Software required: Any internet capable device with standard browser software

For questions about CME credit, contact www.pimed.com

Jointly provided by Postgraduate Institute for Medicine and Urgentcarementor,LLC

Target Audience: This activity is intended for medical providers engaged in the examination of workers required to wear respirators and may undergo pulmonary function testing, or spirometry, as part of that evaluation..

Educational Objectives:

After completing this activity, the participant should be better able to:

  • Recognize that the spirometer used in occupational spirometry testing meets or exceeds ATS/ERS and ISO standards.
  • Determine whether spirometry equipment has been calibrated and/or validated all days tests are conducting and is functioning properly
  • Recognize errors in testing not detected by the equipment
  • Compile essential elements of the Spirometry Procedure Manual
  • Assure technician staff are properly trained
  • Determine whether spirometry tests are technically valid
  • Maintain a quality assurance program
  • Ensure spirometry reports are complete and contain recommended documentation

Faculty: Lawrence Earl, MD

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Urgentcarementor, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty: Lawrence Earl, MD has nothing to disclose.

Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME credit for this activity. During the period January 10, 2017 through January 10, 2019 participants must read the learning objectives and faculty disclosures and study the educational activity. If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com.  On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID and insert the ID number “12078”.  Upon registering and successfully completing the activity evaluation, your certificate will be made available immediately.

Media – Internet

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Unlock the secrets to optimizing your occupational health program.

The NAOHP 2023 Occupational Health Benchmark Study delves into vital factors affecting service delivery. Covering compensation, quality, sales, marketing, and technology, it offers insights to enhance programs.